Royalty Pharma (RPRXN) Q4 2023 Earnings Report
1 Followers
MX:RPRXN Q4 2023 EPS Results
- Actual EPS
- MXN 21.52
- Consensus EPS
- MXN 18.91
- Beat/Miss
- Beat by +MXN 2.60
- One Year Ago EPS
- MXN 29.18
MX:RPRXN Q4 2023 Revenue Results
- Actual Revenue
- MXN 11.16B
- Expected Revenue
- MXN 12.84B
- Beat/Miss
- Missed by -MXN 1.68B
- YoY Revenue Growth
- +5.30%
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 02/15/2024
- Time
- Before Open
- Conference Call
- Thursday, February 15, 2024
MX:RPRXN Upcoming Earnings
Royalty Pharma's next earnings date is estimated for February 16, 2027, based on past reporting schedules.
Q4 2023 Earnings Call Audio
MX:RPRXN Q4 2023 Earnings Call
0:00 / 0:00
Q4 2023 Earnings Slide Deck
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:RPRXN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 16, 2027 | 2026 (Q4) | 29.33- | 27.45 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | 22.1222.62 | 21.97 | 2.98% (+0.66) | |
| Aug 05, 2026 | 2026 (Q2) | 23.8424.74 | 21.37 | 15.78% (+3.37) | |
| May 06, 2026 | 2026 (Q1) | 22.7324.27 | 14.03 | 73.03% (+10.24) | |
| Feb 11, 2026 | 2025 (Q4) | 24.0827.45 | 21.55 | 27.37% (+5.90) | |
| Nov 05, 2025 | 2025 (Q3) | 18.6121.97 | 17.17 | 27.92% (+4.79) | |
| Aug 06, 2025 | 2025 (Q2) | 19.3321.37 | 18 | 18.73% (+3.37) | |
| May 08, 2025 | 2025 (Q1) | 17.8514.03 | 18.31 | -23.42% (-4.29) | |
| Feb 11, 2025 | 2024 (Q4) | 19.7621.55 | 21.52 | 0.17% (+0.04) | |
| Nov 06, 2024 | 2024 (Q3) | 17.3617.17 | 14.78 | 16.22% (+2.40) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
